Iodine-125 irradiation of choroidal melanoma. Clinical experience
Twenty-nine patients with choroidal melanomas were treated with iodine-125 seeds in gold scleral plaques. Iodine-125 emits low energy 25 KeV photons which are attenuated by the side and back of the plaques so that the radiation is directed towards the choroidal tumor. The anticipated therapeutic benefits of using a low energy isotope and directional applicators have been realized. There has been a marked reduction in ocular complications in the nine medium and 20 large melanomas so treated. The complication rate was 34% with a mean follow-up of 38 months. This is a lower complication rate, with longer follow-up, and in larger tumors than that reported with the use of cobalt-60, ruthenium-106 or ion beam. Three patients with large tumors and two patients with medium tumors died of metastasis. This compares favorably to results of similarly sized melanomas treated by enucleation.
- Research Organization:
- North Shore Univ. Hospital, Manhasset, NY
- OSTI ID:
- 5654154
- Journal Information:
- Ophthalmology (Rochester, Minn.); (United States), Journal Name: Ophthalmology (Rochester, Minn.); (United States) Vol. 91:12; ISSN OPHTD
- Country of Publication:
- United States
- Language:
- English
Similar Records
Alternative Dose for Choroidal Melanoma Treated With an Iodine-125 Radioactive Plaque: A Single-Institution Retrospective Study
Irradiation of malignant eyelid melanoma with iodine 125 plaque
Related Subjects
62 RADIOLOGY AND NUCLEAR MEDICINE
BEAMS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
BODY AREAS
COBALT 60
COBALT ISOTOPES
COMPARATIVE EVALUATIONS
DAYS LIVING RADIOISOTOPES
DEATH
DISEASES
ELECTRON CAPTURE RADIOISOTOPES
EVEN-EVEN NUCLEI
EYES
FACE
HEAD
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
IODINE 125
IODINE ISOTOPES
ION BEAMS
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
MEDICINE
MELANOMAS
METASTASES
MINUTES LIVING RADIOISOTOPES
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ODD-ODD NUCLEI
ORGANS
PATIENTS
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
RUTHENIUM 106
RUTHENIUM ISOTOPES
SENSE ORGANS
SIDE EFFECTS
THERAPY
UVEA
YEARS LIVING RADIOISOTOPES